Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Study Information
Alliance Study ID: ACOSOG-Z0030
NCT Study ID (ClinicalTrials.gov): NCT00003831
Disease or Cancer Type: Lung Cancer & Mesothelioma
Alliance Study Chair: Mark S. Allen, MD
Status: COMPLETED
Study Description
RATIONALE: Surgical removal of all lymph nodes in the chest may kill cancer cells that have spread from tumors in the lung. It is not yet known whether complete removal of all lymph nodes in the chest is more effective than removal of selected lymph nodes in treating patients who have stage I or stage II non-small cell lung cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of complete removal of all lymph nodes in the chest with that of selected removal of lymph nodes during lung cancer surgery in treating patients who have stage I or stage II non-small cell lung cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information